Recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease: Preliminary prospective confirmatory trial.

Norio AkutaHiromitsu KumadaShunichirou FujiyamaYusuke KawamuraHitomi SezakiTetsuya HosakaMasahiro KobayashiMariko KobayashiSatoshi SaitohYoshiyuki SuzukiFumitaka SuzukiYasuji AraseKenji Ikeda

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2018)

The present prospective trial showed the high recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease.

Keyphrases

study protocol
phase iii
phase ii
clinical trial
free survival
atopic dermatitis
randomized controlled trial
open label
drug induced